Realistically, he considers a return to normal life in late autumn, the Albert Bourla, the CEO of the American pharmaceutical company Pfizer.
«This was proven by the experience of Israel, where large parts of the population have already been vaccinated with the Biontech / Pfizer, he said in an interview with the German business daily Handelsblatt (which will be published in full in tomorrow's edition) and three other European newspapers (the Italian La Stampa, the French Les Echos and the Spanish El Mundo).
«The coronavirus will become like a kind of flu. We will be vaccinated and live as normally as possible. The Biontech-Pfizer companies' vaccine is 97% effective and also helps fight the highly contagious known variants of the Sars-Cov-2 virus that lead to serious illnesses. If there are new mutations, these could be quickly combated by further developments of the vaccine mRNA», Burla stressed.
«This technology, which is being used for the first time, enables much faster vaccine development than in the past: We can treat any variant of the virus very quickly,» said Pfizer's chief executive officer (CEO).
«In the second quarter of 2021, the two companies (Biontech and Pfizer) will deliver 250 million doses of vaccine in the European Union, four times more than in the first quarter.», promised Burla.
«In a few months, the number of doses will no longer be a problem, there will be enough vaccines,» expects Albert Burla.
The vaccine against COVID-19 of Pfizer and BioNTech, which is currently one of the most expensive among those sold, is no more expensive than a meal and will be distributed without financial gain to poor countries, especially in Africa.
«In Europe, the vaccine costs the same as a meal, but in Africa the vaccine is sold at cost in order to avoid economic barriers to widespread vaccination of the population,» he added.
“Vaccines are priceless. They save lives, they allow economies to reopen, but we sell them for the price of a meal,” he insisted.
